Akorn Inc
AKRX:NASDAQ
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
| 16.57 | 0.38 2.35% | 0.00% | 229,019 | 418.4K |
Market data is delayed by at least 20 minutes.
Latest News Headlines for Akorn Inc
Pre-Market Review: Delcath Systems Inc., Astex Pharma Inc., BioMarin Pharma Inc., and Akorn Inc.
View more recent headlines
Editor Note: For more information about this release, please scroll to bottom.
LONDON, August 21, 2013 /PRNewswire/ --
The U.S. equity market posted some gains on Tuesday, August 20, 2013. The S&P; 500 ended 0.38% higher at 1,652.35, and the NASDAQ Composite closed the day 0.68% higher at 3,613.59. Shares in healthcare companies ended higher, tracking gains in the broader market. The major movers in the sector included Delcath Systems Inc. (NASDAQ: DCTH), Astex Pharmaceuticals (NASDAQ: ASTX), BioMarin Pharmaceuticals Inc. (NASDAQ: BMRN), and Akorn Inc. (NASDAQ: AKRX). AAAResearchReports.com initiated preliminary technical research on DCTH, ASTX, BMRN, and AKRX. These free reports are accessible by signing today at:
Company Background
Akorn, Inc. is a manufacturer and markets a full line of diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital drugs and injectable pharmaceuticals. It operates in three segments: ophthalmic, hospital drugs & injectables, and contract services. It operates pharmaceutical manufacturing plants in the United States at Decatur, Illinois and Somerset, New Jersey, and internationally at Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, R&D; centers in Skokie and Vernon Hills, Illinois and corporate offices in Lake Forest, Illinois. It's customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. On February 28, 2012, the Company, through its wholly owned subsidiary, Akorn India Private Limited, acquired selected assets of Kilitch Drugs (India) Limited, and it also acquired selected assets of NBZ Pharma Limited.
Bid/Size -- / -- | Ask/Size -- / -- |
Price Open 16.17 | Previous Close 16.19 |
Day High 16.74 | Day Low 16.00 |
52wk High/Date 16.74 / 8/26/2013 | 52wk Low/Date 11.73 / 11/6/2012 |
% off 52wk High -1.02% | % off 52wk Low 41.26% |
Beta (5 Yr) 1.0 | Market Capitalization 1.6B |
Shares Outstanding 96.2M | Volatility Avg 32.00 |
EPS(TTM) 0.41 | P/E Ratio 40.2 |
Dividend Announcement -- | Dividend Yield 0.00% |
Ex-Date -- | Date of Record -- |
Payable 0.00 - -- | Payable Date -- |
Last Trade as of 8/26/2013 1:17 PM ET | |
AKRX Akorn Inc vs. Peers
| Peers | |
|---|---|
AKRX Akorn Inc | 21.18% |
AKRX Akorn Inc | 0.00% |
AKRX Akorn Inc | 2.35% |